# Flu mrna (formulation a) PDUFA date and FDA approval status

Canonical: https://sec-api.dev/pdufa/flu-mrna-formulation-a

> Flu mrna (formulation a), sponsored by GSK plc (GSK): 1 recorded catalyst.

Data as of November 16, 2026 (snapshot 20261116T222116Z). Every date quotes the SEC filing or FDA page it came from. Date precision: exact day.

**Free:** every drug page and the next 30 days of the FDA calendar, no account. Calendar API, alerts when a date moves, and full history: https://sec-api.dev/pricing . Free API key: https://sec-api.dev/sign-up?ref=ai-claudebot

## Key facts

| Field | Value |
| --- | --- |
| Drug | flu mrna (formulation a) |
| Codes | GSK6479720A |
| Sponsor | GSK plc (GSK) https://sec-api.dev/companies/gsk/catalysts |
| Indications | [Influenza, Human](https://sec-api.dev/indications/influenza-human) |
| Modality |  |
| FDA designations | none disclosed |

## Timeline

### May 11, 2026: primary completion

- Status: completed. Date confidence: exact. Stage: 2. Indication: Influenza, Human.
- First seen 2026-11-12T03:44:55.771Z, last confirmed 2026-11-16T22:20:01.192Z.
- ClinicalTrials.gov: "NCT07121192 (A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Older): Overall Status COMPLETED; Phase PHASE2; Primary Completion 2026-05-11 (ACTUAL); Lead Sponsor GlaxoSmithKline." https://clinicaltrials.gov/study/NCT07121192

## Same indication

- [Flu mrna (formulation b1)](https://sec-api.dev/pdufa/flu-mrna-formulation-b1) (GSK)
- [Mrna seasonal flu vaccine](https://sec-api.dev/pdufa/mrna-seasonal-flu-vaccine) (GSK)
- [Zanamivir](https://sec-api.dev/pdufa/zanamivir) (GSK)

## Feeds and downloads

- Subscribe (iCal): https://sec-api.dev/pdufa/flu-mrna-formulation-a.ics
- Next 30 days as CSV: https://sec-api.dev/fda-calendar.csv . JSON: https://sec-api.dev/fda-calendar.json . All events (iCal): https://sec-api.dev/fda-calendar.ics
- New or moved PDUFA dates: https://sec-api.dev/pdufa-dates/feed.xml (RSS), https://sec-api.dev/pdufa-dates/feed.json (JSON Feed)
- FDA approvals: https://sec-api.dev/fda-approvals-today/feed.xml (RSS), https://sec-api.dev/fda-approvals-today/feed.json (JSON Feed)
- License: CC BY 4.0 for the public 30-day window (https://sec-api.dev/biotech/license.txt). Full history: https://sec-api.dev/pricing

## Cite this page

sec-api.dev. "Flu mrna (formulation a) PDUFA date and FDA approval status." Biotech catalyst calendar, data as of November 16, 2026 (snapshot 20261116T222116Z). https://sec-api.dev/pdufa/flu-mrna-formulation-a

```bibtex
@misc{secapidev_pdufa_flu_mrna_formulation_a_20261116,
  title        = {Flu mrna (formulation a) PDUFA date and FDA approval status},
  author       = {{sec-api.dev}},
  year         = {2026},
  month        = {nov},
  howpublished = {\url{https://sec-api.dev/pdufa/flu-mrna-formulation-a}},
  note         = {Biotech catalyst calendar, data as of 2026-11-16, snapshot 20261116T222116Z. Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source.}
}
```

```json
{"type":"dataset","id":"secapidev_pdufa_flu_mrna_formulation_a_20261116","title":"Flu mrna (formulation a) PDUFA date and FDA approval status","publisher":"sec-api.dev","URL":"https://sec-api.dev/pdufa/flu-mrna-formulation-a","issued":{"date-parts":[[2026,11,16]]},"version":"20261116T222116Z","license":"https://creativecommons.org/licenses/by/4.0/","note":"Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source."}
```

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Food and Drug Administration or the U.S. Securities and Exchange Commission. Dates are as stated by sponsors and FDA; the FDA can act before or after a target date. Not investment advice.
